Literature DB >> 1458561

Mechanistic implications of alterations in HL-60 cell nascent DNA after exposure to 1-beta-D-arabinofuranosylcytosine.

D D Ross1, D P Cuddy, N Cohen, D R Hensley.   

Abstract

To improve our understanding of the mechanism of 1-beta-D-arabinofuranosylcytosine (ara-C) incorporation into DNA, we investigated the physical properties (size, position of nucleoside incorporation) of small fragments of nascent DNA (nDNA) obtained by pH-step alkaline elution of intact HL-60 cells following their exposure to ara-C. In the pH-step alkaline elution procedure, the smallest fragments of nDNA elute at pH 11. Anion-exchange high-performance liquid chromatography (HPLC) of nDNA obtained by 1 h elution at pH 11.0 of lysed HL-60 cells revealed a preponderance of nDNA fragments ranging from 0.5 to 40 kb in control ([3H]-dThd-labeled) cells. Exposure of cells to ara-C (0.8-1 microM) resulted in a loss of the preponderance of radiolabel in fragments of 0.5-40 kb along with redistribution of the radiolabel (from [3H]-dThd or [3H]-ara-C) into smaller nDNA fragments (predominantly < 100 bases in length) as determined by HPLC. We used the ability of pH-step alkaline elution to provide these small nDNA fragments produced by ara-C to investigate the paradoxical behavior of ara-C as a chain terminator in cell-free DNA synthetic systems while being incorporated into an internucleotide position in intact cells. Following the digestion of purified nDNA with micrococcal nuclease and spleen phosphodiesterase II, the proportion of radiolabel in 3'-dNMP (indicating an internucleotide position) or free nucleoside (indicating a chain terminus position) was determined by reverse-phase HPLC. In digests of prelabeled genomic DNA, as expected, > 90% of the radiolabel from [14C]-dThd or [3H]-ara-C was found to exist in an internucleotide position (as determined by co-chromatography with authentic 3'-dTMP or 3'-ara-CMP). In contrast, digests of nDNA that eluted at pH 11.0 revealed a significantly higher proportion of radiolabel in the chain terminus position (29%-35%) when the nDNA was obtained from cells exposed to 1 microM [3H]-ara-C as compared with cells exposed to [3H]-dThd or [3H]-dCyd alone (< 10%). These data obtained from pH-step alkaline elution of intact cells suggest that by causing the inhibition of chain elongation while failing to inhibit the formation of new nDNA replication intermediates, ara-C exposure leads to the production of very small nDNA fragments. This relative chain-terminating effect of ara-C is most apparent in the small nDNA replication fragments that elute at pH 11.0.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1458561     DOI: 10.1007/bf00695996

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  26 in total

1.  Enzymatic synthesis of deoxyribonucleic acid. VIII. Frequencies of nearest neighbor base sequences in deoxyribonucleic acid.

Authors:  J JOSSE; A D KAISER; A KORNBERG
Journal:  J Biol Chem       Date:  1961-03       Impact factor: 5.157

2.  Sequence-specific effects of ara-5-aza-CTP and ara-CTP on DNA synthesis by purified human DNA polymerases in vitro: visualization of chain elongation on a defined template.

Authors:  A J Townsend; Y C Cheng
Journal:  Mol Pharmacol       Date:  1987-09       Impact factor: 4.436

3.  Studies in mouse L-cells on the incorporation of 1-beta-D-arabinofuranosylcytosine into DNA and on inhibition of DNA polymerase by 1-beta-D-arabinofuranosylcytosine 5'-triphosphate.

Authors:  F L Graham; G F Whitmore
Journal:  Cancer Res       Date:  1970-11       Impact factor: 12.701

4.  Studies on the mechanism of action of cytosine arabinoside.

Authors:  D W Kufe; P P Major
Journal:  Med Pediatr Oncol       Date:  1982

5.  Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation.

Authors:  A H Wyllie
Journal:  Nature       Date:  1980-04-10       Impact factor: 49.962

6.  Evidence for a new mechanism of cytotoxicity of 1-beta-D arabinofuranosylcytosine.

Authors:  D M Woodcock; R M Fox; I A Cooper
Journal:  Cancer Res       Date:  1979-04       Impact factor: 12.701

7.  Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-beta-D-arabinofuranosylcytosine.

Authors:  H Gunji; S Kharbanda; D Kufe
Journal:  Cancer Res       Date:  1991-01-15       Impact factor: 12.701

8.  Effects of 1-beta-D-arabinofuranosylcytosine on DNA replication intermediates monitored by pH-step alkaline elution.

Authors:  D D Ross; S R Chen; D P Cuddy
Journal:  Cancer Res       Date:  1990-05-01       Impact factor: 12.701

9.  Functional consequences of the arabinosylcytosine structural lesion in DNA.

Authors:  T Mikita; G P Beardsley
Journal:  Biochemistry       Date:  1988-06-28       Impact factor: 3.162

10.  Instability of (ara-C) DNA under alkaline conditions.

Authors:  P P Major; E M Egan; D Herrick; D W Kufe
Journal:  Biochem Pharmacol       Date:  1982-03-01       Impact factor: 5.858

View more
  4 in total

1.  Cytarabine-induced destabilization of a model Okazaki fragment.

Authors:  W H Gmeiner; A Skradis; R T Pon; J Liu
Journal:  Nucleic Acids Res       Date:  1998-05-15       Impact factor: 16.971

2.  Phase I and pharmacokinetic study of 3'-C-ethynylcytidine (TAS-106), an inhibitor of RNA polymerase I, II and III,in patients with advanced solid malignancies.

Authors:  Lisa A Hammond-Thelin; Melanie B Thomas; Michiko Iwasaki; James L Abbruzzese; Yvonne Lassere; Christina A Meyers; Paulo Hoff; Johann de Bono; Jody Norris; Hitoshi Matsushita; Akira Mita; Eric K Rowinsky
Journal:  Invest New Drugs       Date:  2010-09-14       Impact factor: 3.850

3.  Structural insights into mutagenicity of anticancer nucleoside analog cytarabine during replication by DNA polymerase η.

Authors:  Olga Rechkoblit; Robert E Johnson; Angeliki Buku; Louise Prakash; Satya Prakash; Aneel K Aggarwal
Journal:  Sci Rep       Date:  2019-11-08       Impact factor: 4.379

Review 4.  Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism.

Authors:  Nikolaos Tsesmetzis; Cynthia B J Paulin; Sean G Rudd; Nikolas Herold
Journal:  Cancers (Basel)       Date:  2018-07-23       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.